Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 84.00 | |
5 mg | In stock | $ 197.00 | |
10 mg | In stock | $ 328.00 | |
25 mg | In stock | $ 558.00 | |
50 mg | In stock | $ 788.00 | |
100 mg | In stock | $ 1,120.00 | |
500 mg | In stock | $ 2,230.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 288.00 |
Description | Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies. |
Targets&IC50 | EGFR (T790M):0.37 nM, EGFR (L858R/T790M):0.29 nM, EGFR (del19/T790M):0.21 nM |
In vitro | Almonertinib shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM)[1]. Additionaly, HS-10296 could also inhibit other EGFR sensitive mutations, including G719X, del19, L858R and L861Q[2]. |
Molecular Weight | 621.75 |
Formula | C31H39N7O5S |
CAS No. | 2134096-06-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (48.25 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Almonertinib mesylate 2134096-06-1 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR Almonertinib EGFR tyrosine kinase inhibitor Inhibitor HER1 ErbB-1 third-generation HS-10296 HS 10296 orally available inhibit Epidermal growth factor receptor irreversible Almonertinib Mesylate HS10296 non-small cell lung cancer inhibitor